A clinical study to see the effect of some Ayurvedic formulation in the form of nasal administration in the treatment of simple myopia.
- Conditions
- Health Condition 1: H521- Myopia
- Registration Number
- CTRI/2020/11/029057
- Lead Sponsor
- Sane Guruji Arogya Kendra
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 74
1) Patient having signs and symptoms of
Prathama and Dwitiya Patalagata
Timir a will be included i.e blurriness, difficult to distant vision, visual
hallucination.
2) The patient of age from 19 to 40 years,irrespective of gender
3) Patient who have low myopia
3D in both eyes.
4)Patients having a vision 6/9
or less i.e. 6/12, 6/18, 6/24, 6/36, 6/60
5) Patient
yogya for Nasya karma
1) Know case of Myopia associated with other ocular diseases such as Cataract glaucoma, Retinal diseases, Iridocyclitis, Vitreous opacity, Chorioretinitis.
2) Know case of Congenital Myopia, Pathological Myopia and other types of Myopia.
3) Patients suffering from infectious diseases e.g. bacterial,viral or Fungalconjunctivitis, Blepharitis, Tubercular infection.
4) Refractive errors like Hypermetropia, Astigmatism.
5) Patients having refractive error more than -3D in both eyes
6) Patients having known case of Diabetes Mellitus, Hypertension, HIV,HBSAg Tuberculosis, Thyroid disorder.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method A clinical study to evaluate efficacy of Bhingaraja Taila Nasya in Prathama and Dwitiya Patalgata Timir w.r.t Simple Myopia. Parameter of efficacy will be visual acuity before and after treatmentTimepoint: Duration of therapy is 3 weeks for each patient and the total duration of trial is 18 month
- Secondary Outcome Measures
Name Time Method comparison between efficacy <br/ ><br>of Bhringaraja Taila Nasya and Abhijit Taila Nasya in <br/ ><br>Prathama and Dwitiya Patalgata Timir w.r.t <br/ ><br>Simple MyopiaTimepoint: Each patiennt will receive therapy for 3 weeks. Total duration of the study will 18 months.